{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T11:33:04Z","timestamp":1781350384728,"version":"3.54.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:00:00Z","timestamp":1722297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:00:00Z","timestamp":1722297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>This study explored similarities and differences among Chinese patients and rheumatologists in their attitudes towards and perceptions of traditional Chinese medicine (TCM) for Sj\u00f6gren\u2019s syndrome (SS), including analyzing factors that influenced their decision making.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>An anonymous questionnaire was used to conduct a multicenter survey among patients with SS at three tertiary care medical centers in Beijing and among rheumatology clinicians at several hospitals across China. Results were analyzed using descriptive statistics.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There were 942 valid questionnaires from patients from 31 provinces and cities in China, with a male-to-female ratio of approximately 1:14, a mean age of 48.81\u00a0years, and a median disease duration of 7 (4, 10) years. There were 320 valid questionnaires from rheumatologists, covering 30 provinces and cities in China, with a male-to-female ratio of approximately 0.87:1, a mean age of 48\u00a0years, and a median work duration of 10.5 (6, 15) years. The rheumatologists treated a median of 15 (11, 50) SS cases per month, and the median proportion of SS to all rheumatic diseases was 6.66% (6\u201310%). Many patients believed TCM could cure the root of the disease, and the most expected TCM therapies were TCM patent prescriptions and medicinal teas. Conversely, rheumatologists placed high value on the efficacy of TCM, and most commonly prescribed Chinese herbal decoctions. Most doctor-patient groups were positive about TCM treatment, citing the low side effects as the major advantage. Regression analysis showed that for patients over 40\u00a0years old with a course of disease\u2009&gt;\u20094\u00a0years, the probability of using TCM has increased by 1\u20136 times; the probability of recommending TCM in clinical work of doctors who have worked for more than 15\u00a0years, TCM and integrated traditional Chinese and western medicine has increased 1\u20132 times.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>TCM has become widely accepted and earned attention from doctor-patient groups, especially among older patients and experienced rheumatologists. However, negative prejudices and absence of accurate information about TCM treatments and SS itself require improvement. The contradiction between TCM dosage form and efficacy is a major problem, and patient demand for convenient and efficient TCM patent preparations suggests future work should focus on developing TCM patent preparations with clear compositions and mechanisms.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12906-024-04591-2","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T18:03:05Z","timestamp":1722362585000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Traditional Chinese medicine for sj\u00f6gren\u2019s syndrome: a national survey of attitudes and perceptions among Chinese patients and rheumatologists"],"prefix":"10.1186","volume":"24","author":[{"given":"Ruihua","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haodong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuebo","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopo","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,30]]},"reference":[{"issue":"1","key":"4591_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s12967-021-03051-6","volume":"19","author":"JJ Lee","year":"2021","unstructured":"Lee JJ, Park YJ, Park M, Yim HW, Park SH, Kwok SK. Longitudinal analysis of symptom-based clustering in patients with primary Sjogren\u2019s syndrome: a prospective cohort study with a 5-year follow-up period. J Transl Med. 2021;19(1):394.","journal-title":"J Transl Med"},{"issue":"10","key":"4591_CR2","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1002\/acr.23173","volume":"69","author":"G Maciel","year":"2017","unstructured":"Maciel G, Crowson CS, Matteson EL, Cornec D. Prevalence of primary Sj\u00f6gren\u2019s syndrome in a US population-based cohort. Arthritis Care Res (Hoboken). 2017;69(10):1612\u20136.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"4591_CR3","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1056\/NEJMc1804598","volume":"379","author":"S Lal","year":"2018","unstructured":"Lal S. Primary Sjogren\u2019s syndrome. N Engl J Med. 2018;379(1):96\u20137.","journal-title":"N Engl J Med"},{"issue":"3","key":"4591_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jama.2014.7682","volume":"312","author":"JE Gottenberg","year":"2014","unstructured":"Gottenberg JE, Ravaud P, Pu\u00e9chal X, Le Guern V, Sibilia J, Goeb V, Larroche C, Dubost JJ, Rist S, Saraux A, et al. Effects of hydroxychloroquine on symptomatic improvement in primary Sj\u00f6gren syndrome: the JOQUER randomized clinical trial. JAMA. 2014;312(3):249\u201358.","journal-title":"JAMA"},{"issue":"01","key":"4591_CR5","first-page":"37","volume":"40","author":"D-W Yang","year":"2022","unstructured":"Yang D-W, Chen Y-S, Li C-Y. Double disease exploration of Sj\u00f6gren\u2019s syndrome. Chinese J Trad Chinese Med. 2022;40(01):37\u201340 [Chinese with abstract in English].","journal-title":"Chinese J Trad Chinese Med."},{"issue":"10","key":"4591_CR6","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1093\/rheumatology\/kex375","volume":"56","author":"EJ Price","year":"2017","unstructured":"Price EJ, Rauz S, Tappuni AR, Sutcliffe N, Hackett KL, Barone F, Granata G, Ng WF, Fisher BA, Bombardieri M, et al. British society for rheumatology standards, guideline and audit working group. The British society for rheumatology guideline for the management of adults with primary Sj\u00f6gren\u2019s syndrome. Rheumatology (Oxford). 2017;56(10):1643\u20137.","journal-title":"Rheumatology (Oxford)."},{"issue":"1","key":"4591_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2019-216114","volume":"79","author":"M Ramos-Casals","year":"2020","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Bombardieri S, Bootsma H, De Vita S, D\u00f6rner T, Fisher BA, Gottenberg JE, Hernandez-Molina G, Kocher A, et al. EULAR-Sj\u00f6gren syndrome task force group. EULAR recommendations for the management of Sj\u00f6gren\u2019s syndrome with topical and systemic therapies. Ann Rheum Dis. 2020;79(1):3\u201318.","journal-title":"Ann Rheum Dis."},{"issue":"06","key":"4591_CR8","first-page":"115","volume":"29","author":"Z Guo","year":"2022","unstructured":"Guo Z, Tang X, Xu H, Liu R, Wu H, Zhou X, Jin Y, He J, Wang B, Jiang Q. Survey and analysis of Chinese medicine application in 626 patients with Sj\u00f6gren\u2019s syndrome. Chinese J Trad Chinese Med Inform. 2022;29(06):115\u20139 [Chinese with abstract in English].","journal-title":"Chinese J Trad Chinese Med Inform."},{"issue":"21","key":"4591_CR9","first-page":"2339","volume":"26","author":"Y Zhu","year":"2017","unstructured":"Zhu Y, Zhang K, Yang L. Effects of Qi Wei Bai Zhu San combined with Sheng Wei San on serum IgA, IgM, IgG and T lymphocyte subsets in patients with Sj\u00f6gren\u2019s syndrome. J Modern Trad Chinese West Med. 2017;26(21):2339\u201341 [Chinese with abstract in English].","journal-title":"J Modern Trad Chinese West Med."},{"issue":"6","key":"4591_CR10","first-page":"763","volume":"41","author":"L Jiang","year":"2021","unstructured":"Jiang L, Liu L, Li X. Benefiting Qi, nourishing Yin, invigorating blood and dispelling wind in the treatment of primary Sj\u00f6gren\u2019s syndrome. Jilin Chinese Med. 2021;41(6):763\u20136 [Chinese with abstract in English].","journal-title":"Jilin Chinese Med."},{"issue":"11","key":"4591_CR11","first-page":"1036","volume":"37","author":"B Wang","year":"2018","unstructured":"Wang B, Gu W, Ma C, Wen B, Shao P, Shi Y, Chen A, Lu S. Clinical observation of Yiqi Shengjin San in the treatment of Qi-Yin two deficiency evidence in Sj\u00f6gren\u2019s syndrome. Beijing Trad Chin Med. 2018;37(11):1036\u20138+1042 [Chinese with abstract in English].","journal-title":"Beijing Trad Chin Med."},{"issue":"1","key":"4591_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12906-017-1559-9","volume":"17","author":"Q Jiang","year":"2017","unstructured":"Jiang Q, Zhang H, Pang R, Chen J, Liu Z, Zhou X. Acupuncture for primary Sj\u00f6gren syndrome (pSS) on symptomatic improvements: study protocol for a randomized controlled trial. BMC Complement Altern Med. 2017;17(1):61.","journal-title":"BMC Complement Altern Med"},{"issue":"15","key":"4591_CR13","doi-asserted-by":"publisher","first-page":"e15178","DOI":"10.1097\/MD.0000000000015178","volume":"98","author":"Y Zi","year":"2019","unstructured":"Zi Y, Ji M, Deng Y, Qin Y, Wang R, Meng H, Jin M. The effectiveness and safety of moxibustion for dry eye: protocol for a systematic review. Medicine (Baltimore). 2019;98(15):e15178. [Chinese with abstract in English]","journal-title":"Medicine (Baltimore)."},{"key":"4591_CR14","unstructured":"Qi W. Study on clinical efficacy evaluation of acupuncture for primary Sj\u00f6gren\u2019s syndrome with anxiety and depression. Chinese Acad Trad Chinese Med. 2019. [Chinese with abstract in English]."},{"issue":"10","key":"4591_CR15","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1007\/s11655-015-2323-y","volume":"21","author":"GL Wu","year":"2015","unstructured":"Wu GL, Wu NY, Li TY, Fan YS, Yu GY, Lu WW. Effect of Chinese herbal medicines for nourishing yin, supplementing qi, and activating blood on reproductive endocrine activity and immune functions in patients with primary Sjogren\u2019s syndrome. Chin J Integr Med. 2015;21(10):778\u201383.","journal-title":"Chin J Integr Med"},{"issue":"01","key":"4591_CR16","first-page":"26","volume":"34","author":"B Li","year":"2017","unstructured":"Li B, Xue L, Park X, Zhu J. Clinical observation of the effect of acupuncture and medicine combination on disease related indices of primary Sj\u00f6gren\u2019s syndrome. Tianjin Chinese Med. 2017;34(01):26\u201331 [Chinese with abstract in English].","journal-title":"Tianjin Chinese Med."},{"issue":"8","key":"4591_CR17","first-page":"1005","volume":"40","author":"R Li","year":"2020","unstructured":"Li R, Li W, Qin S. Clinical observation on the treatment of primary Sj\u00f6gren\u2019s syndrome by combining internal administration of Wu Mei Sheng Jin Hua Tang with external application of Er Hua Tang. Chinese J Integr Med. 2020;40(8):1005\u20136 [Chinese with abstract in English].","journal-title":"Chinese J Integr Med."},{"key":"4591_CR18","unstructured":"Shi H. Clinical study on the treatment of primary Sj\u00f6gren\u2019s syndrome with qi deficiency and fluid deficiency with run dry drink. Beijing Univ Trad Chinese Med. 2018. [Chinese with abstract in English]."},{"issue":"3","key":"4591_CR19","first-page":"213","volume":"21","author":"Y Jin","year":"2017","unstructured":"Jin Y, He J. 2016 American college of rheumatology\/European league against rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome. Chinese J Rheumatol. 2017;21(3):213 [Chinese with abstract in English].","journal-title":"Chinese J Rheumatol."},{"issue":"20","key":"4591_CR20","first-page":"1740","volume":"58","author":"J Jiao","year":"2017","unstructured":"Jiao J, Zhang R, Jiang Q. A survey on the level of awareness of fibromyalgia among TCM rheumatologists. J Trad Chinese Med. 2017;58(20):1740\u20132+1759 [Chinese with abstract in English].","journal-title":"J Trad Chinese Med."},{"issue":"12","key":"4591_CR21","first-page":"1365","volume":"10","author":"P Lai","year":"2010","unstructured":"Lai P, He J, Huang Y, et al. A survey on the current situation of diagnosis and treatment decision of Sj\u00f6gren\u2019s syndrome and analysis of related factors. China Drugs Clin. 2010;10(12):1365\u20137 [Chinese with abstract in English].","journal-title":"China Drugs Clin."},{"issue":"2","key":"4591_CR22","first-page":"225","volume":"44","author":"J He","year":"2012","unstructured":"He J, Ding Y, Li Y, et al. Analysis of clinical characteristics of patients with primary Sj\u00f6gren\u2019s syndrome at first diagnosis. J Peking Univ (Med Ed). 2012;44(2):225\u20138 [Chinese with abstract in English].","journal-title":"J Peking Univ (Med Ed)."},{"issue":"1","key":"4591_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1200\/JCO.2010.28.0107","volume":"29","author":"K Cocks","year":"2011","unstructured":"Cocks K, King MT, Velikova G, et al. Evidence-based guidelines for determination of sample size and interpretation of the European organisation for the research and treatment of cancer quality of life questionnaire core 30. J Clin Oncol. 2011;29(1):89\u201396.","journal-title":"J Clin Oncol"},{"issue":"11","key":"4591_CR24","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","volume":"74","author":"B Qin","year":"2015","unstructured":"Qin B, Wang J, Yang Z, et al. Epidemiology of primary Sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis. Ann Rheum Dis. 2015;74(11):1983\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"4591_CR25","first-page":"766","volume":"14","author":"Chinese Medical Association","year":"2010","unstructured":"Chinese Medical Association, Rheumatology Branch. Guidelines for the diagnosis and treatment of Sj\u00f6gren\u2019s syndrome. Chinese J Rheumatol. 2010;14(11):766\u20138.","journal-title":"Chinese J Rheumatol"},{"issue":"4","key":"4591_CR26","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/1756-185X.12583","volume":"18","author":"X Li","year":"2015","unstructured":"Li X, Xu B, Ma Y, et al. Clinical and laboratory profiles of primary Sjogren\u2019s syndrome in a Chinese population: a retrospective analysis of 315 patients. Int J Rheum Dis. 2015;18(4):439\u201346.","journal-title":"Int J Rheum Dis"},{"key":"4591_CR27","unstructured":"Zhang F, Li Y. National multicenter survey on the current status of 640 patients with primary Sj\u00f6gren\u2019s syndrome. Chinese Medical Association, Chinese Medical Association Rheumatology Branch. Proceedings of the 17th National Rheumatology Conference. Chinese Medical Association, Rheumatology Branch of Chinese Medical Association: Chinese Medical Association. 2012;16:25. [Chinese with abstract in English]."},{"issue":"11","key":"4591_CR28","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","volume":"74","author":"B Qin","year":"2015","unstructured":"Qin B, Wang J, Yang Z, Yang M, Ma N, Huang F, Zhong R. Epidemiology of primary Sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis. Ann Rheum Dis. 2015;74(11):1983\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"4591_CR29","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.mayocp.2017.01.020","volume":"92","author":"G Maciel","year":"2017","unstructured":"Maciel G, Crowson CS, Matteson EL, Cornec D. Incidence and mortality of rheumatologist-diagnosed primary Sj\u00f6gren syndrome: Time trends over a 40-year period in a population-based US cohort. Mayo Clin Proc. 2017;92(5):734\u201343.","journal-title":"Mayo Clin Proc"},{"key":"4591_CR30","first-page":"95","volume":"02","author":"T Wu","year":"2019","unstructured":"Wu T, Ming B, Dong L. Current status of diagnosis and treatment of Sj\u00f6gren\u2019s syndrome. J Inter Med Acute Cri Care. 2019;02:95\u20137+102 [Chinese with abstract in English].","journal-title":"J Inter Med Acute Cri Care."},{"key":"4591_CR31","first-page":"68","volume":"34","author":"Y Wu","year":"2018","unstructured":"Wu Y. Exploration and clinical application of early diagnosis methods for rheumatic immune diseases. Elect J Clin Med Lit. 2018;34:68\u20139 [Chinese with abstract in English].","journal-title":"Elect J Clin Med Lit."},{"issue":"4","key":"4591_CR32","first-page":"307","volume":"59","author":"L Jia","year":"2018","unstructured":"Jia L, Zhao N, Shi M, Wang X, Yan X, Lai B, Liu Z, Liu J. A cross-sectional survey of 1286 patients with type 2 diabetes mellitus on their willingness for Chinese medicine treatment. J Tradit Chin Med. 2018;59(4):307\u201311.","journal-title":"J Tradit Chin Med"},{"issue":"2","key":"4591_CR33","doi-asserted-by":"publisher","first-page":"102447","DOI":"10.1016\/j.autrev.2019.102447","volume":"19","author":"G Sambataro","year":"2020","unstructured":"Sambataro G, Ferro F, Orlandi M, Sambataro D, Torrisi SE, Quartuccio L, Vancheri C, Baldini C, Matucci CM. Clinical, morphological features and prognostic factors associated with interstitial lung disease in primary Sj\u04e7gren\u2019s syndrome: a systematic review from the Italian society of rheumatology. Autoimmun Rev. 2020;19(2):102447.","journal-title":"Autoimmun Rev"},{"issue":"5","key":"4591_CR34","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1007\/s10067-019-04906-6","volume":"39","author":"T Zhang","year":"2020","unstructured":"Zhang T, Yuan F, Xu L, Sun W, Liu L, Xue J. Characteristics of patients with primary Sj\u00f6gren\u2019s syndrome associated interstitial lung disease and relevant features of disease progression. Clin Rheumatol. 2020;39(5):1561\u20138.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"4591_CR35","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s40744-020-00264-x","volume":"8","author":"O Aiyegbusi","year":"2021","unstructured":"Aiyegbusi O, McGregor L, McGeoch L, Kipgen D, Geddes CC, Stevens KI. Renal disease in primary Sj\u00f6gren\u2019s syndrome. Rheumatol Ther. 2021;8(1):63\u201380.","journal-title":"Rheumatol Ther"},{"issue":"1","key":"4591_CR36","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12868-018-0427-y","volume":"19","author":"W Ye","year":"2018","unstructured":"Ye W, Chen S, Huang X, Qin W, Zhang T, Zhu X, Zhu X, Lin C, Wang X. Clinical features and risk factors of neurological involvement in Sj\u00f6gren\u2019s syndrome. BMC Neurosci. 2018;19(1):26.","journal-title":"BMC Neurosci"},{"issue":"7","key":"4591_CR37","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1080\/1744666X.2019.1624527","volume":"15","author":"EH van der Heijden","year":"2019","unstructured":"van der Heijden EH, Hartgring SA, Kruize AA, Radstake TR, van Roon JA. Additive immunosuppressive effect of leflunomide and hydroxychloroquine supports rationale for combination therapy for Sj\u00f6gren\u2019s syndrome. Expert Rev Clin Immunol. 2019;15(7):801\u20138.","journal-title":"Expert Rev Clin Immunol"},{"issue":"5 Suppl 61","key":"4591_CR38","first-page":"S156","volume":"28","author":"M Winzer","year":"2010","unstructured":"Winzer M, Aringer M. Use of methotrexate in patients with systemic lupus erythematosus and primary Sj\u00f6gren\u2019s syndrome. Clin Exp Rheumatol. 2010;28(5 Suppl 61):S156\u20139.","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"4591_CR39","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s11655-019-3226-0","volume":"26","author":"JQ Hou","year":"2020","unstructured":"Hou JQ, Xue L. Challenges in treatment of primary Sj\u00f6gren\u2019s syndrome and opportunities for Chinese medicine. Chin J Integr Med. 2020;26(7):483\u20135.","journal-title":"Chin J Integr Med"},{"issue":"04","key":"4591_CR40","first-page":"443","volume":"30","author":"M Wang","year":"2021","unstructured":"Wang M, Xu Z, Liu Y. New progress of Chinese and western medicine treatment for primary Sj\u00f6gren\u2019s syndrome. J Mod Trad Chinese West Med. 2021;30(04):443\u20138 [Chinese with abstract in English].","journal-title":"J Mod Trad Chinese West Med."},{"issue":"12","key":"4591_CR41","first-page":"1653","volume":"33","author":"G Wu","year":"2013","unstructured":"Wu G, Pu X, Li T, Yu G, Lu W, Fan Y. Effects of nourishing Yin, benefiting Qi and activating blood formula on Th1\/Th2 immune balance in serum and submandibular gland of NOD mice with Sj\u00f6gren\u2019s syndrome. Chinese J Integ Med. 2013;33(12):1653\u20137 [Chinese with abstract in English].","journal-title":"Chinese J Integ Med."},{"issue":"11","key":"4591_CR42","first-page":"6347","volume":"36","author":"H Nie","year":"2021","unstructured":"Nie H, Xu L, Li G, Ye Y, Xie M, Liu H, Zhu W. Current status and discussion on the development of modern dosage forms of proprietary Chinese medicines. Chinese J Trad Chinese Med. 2021;36(11):6347\u201351 [Chinese with abstract in English].","journal-title":"Chinese J Trad Chinese Med."},{"issue":"11","key":"4591_CR43","first-page":"1453","volume":"20","author":"X Sun","year":"2018","unstructured":"Sun X, Yu F, Xiao W, Xu L, Xiao P. Research progress of modern applications of Mai Dong. Chinese Mod Trad Chinese Med. 2018;20(11):1453\u20138 [Chinese with abstract in English].","journal-title":"Chinese Mod Trad Chinese Med."},{"issue":"7","key":"4591_CR44","doi-asserted-by":"publisher","first-page":"8215","DOI":"10.21037\/apm-21-256","volume":"10","author":"Y Luo","year":"2021","unstructured":"Luo Y, Zhang Y, Kuai L, Xing M, Ru Y, Luo Y, Liu L, Chen J, Li B, Li X. Efficacy and safety of Tripterygium glycosides in Sj\u00f6gren\u2019s syndrome treatment: evidence from 12 randomized controlled trials. Ann Palliat Med. 2021;10(7):8215\u201331.","journal-title":"Ann Palliat Med"},{"issue":"04","key":"4591_CR45","first-page":"342","volume":"40","author":"L Zhang","year":"2021","unstructured":"Zhang L, Chen J, Luo J, He Q, Xu C, Yu X, Tao Q. Efficacy of dry rinse formula combined with hydroxychloroquine in the treatment of primary Sj\u00f6gren\u2019s syndrome in 60 cases. Beijing Trad Chinese Med. 2021;40(04):342\u20134 [Chinese with abstract in English].","journal-title":"Beijing Trad Chinese Med."}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-024-04591-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-024-04591-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-024-04591-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T18:04:15Z","timestamp":1722362655000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-024-04591-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,30]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4591"],"URL":"https:\/\/doi.org\/10.1186\/s12906-024-04591-2","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,30]]},"assertion":[{"value":"6 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved by the Ethics Committee of Guanganmen Hospital, China Academy of Chinese Medical Sciences before initiation of this study (2022-264-KY). Informed consent was obtained from all participants.All necessary permissions for conducting the research were obtained from the relevant administrators and all methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"291"}}